CooperVision is one of the world's largest contact lens manufacturers and the vision care unit of The Cooper Companies, a publicly traded medical device company. The CooperVision name dates to 1980, and the business has grown substantially through acquisitions, including Ocular Sciences in 2005 and Sauflon Pharmaceuticals in 2014. Headquartered in San Ramon, California, CooperVision manufactures lenses at facilities in the United States, the United Kingdom, Hungary, Costa Rica, and Puerto Rico, and sells in over 130 countries. Its portfolio covers daily disposable, two-week, and monthly soft lenses across the major material technologies. Flagship families include Biofinity, a widely fitted monthly silicone hydrogel line; MyDay and clariti 1 day daily disposables; and Proclear. The company is known for its breadth in specialty lenses, offering one of the industry's largest ranges of toric lenses for astigmatism and multifocal designs for presbyopia. CooperVision also makes MiSight 1 day, the first soft contact lens approved by the US FDA to slow the progression of myopia in children aged 8 to 12 at initiation of treatment, which has become a significant product in the growing myopia management category. The parent Cooper Companies reports annual revenue near four billion US dollars, with CooperVision contributing the majority. The brand competes with Johnson & Johnson Vision, Alcon, and Bausch + Lomb, and holds a leading share in several regional soft lens markets.
coopervision.com/ →